Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z. & Pierce, B. F. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 21, 626–636 (2021).

CAS  PubMed  PubMed Central  Google Scholar 

Files, J. K. et al. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses. JCI Insight 6, e151544 (2021).

PubMed Central  Google Scholar 

Lamers, M. M. et al. SARS-CoV-2 productively infects human gut enterocytes. Science 369, 50–54 (2020).

CAS  PubMed  Google Scholar 

Zang, R. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol. 5, eabc3582 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Zuo, T. et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 70, 276–284 (2020).

PubMed  Google Scholar 

Xiao, F. et al. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg. Infect. Dis. 26, 1920 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Natarajan, A. et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med 3, 371–387 (2022).

CAS  PubMed  Google Scholar 

Zollner, A. et al. Post-acute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 163, 495–506 (2022).

CAS  PubMed  Google Scholar 

Cheung, K. S. et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 159, 81–95 (2020).

CAS  PubMed  Google Scholar 

Mao, R. et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 667–678 (2020).

PubMed  PubMed Central  Google Scholar 

Song, Y. et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut 69, 1143–1144 (2020).

CAS  PubMed  Google Scholar 

Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323, 1061–1069 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392–400 (2018).

CAS  PubMed  PubMed Central  Google Scholar 

Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).

CAS  PubMed  Google Scholar 

Kurilshikov, A. et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat. Genet. 53, 156–165 (2021).

CAS  PubMed  PubMed Central  Google Scholar 

Wolter, M. et al. Leveraging diet to engineer the gut microbiome. Nat. Rev. Gastroenterol. Hepatol. 18, 885–902 (2021).

CAS  PubMed  Google Scholar 

Ruff, W. E., Greiling, T. M. & Kriegel, M. A. Host–microbiota interactions in immune-mediated diseases. Nat. Rev. Microbiol. 18, 521–538 (2020).

CAS  PubMed  Google Scholar 

Groves, H. T., Higham, S. L., Moffatt, M. F., Cox, M. J. & Tregoning, J. S. Respiratory viral infection alters the gut microbiota by inducing inappetence. mBio 11, e03236-19 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Zhang, D. et al. The cross-talk between gut microbiota and lungs in common lung diseases. Front. Microbiol. 11, 301 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Sun, Z. et al. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med. 20, 24 (2022).

CAS  PubMed  PubMed Central  Google Scholar 

Vatanen, T. et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 842–853 (2016).

CAS  PubMed  PubMed Central  Google Scholar 

Anand, S. & Mande, S. S. Diet, microbiota and gut-lung connection. Front. Microbiol. 9, 2147 (2018).

PubMed  PubMed Central  Google Scholar 

Parrot, T. et al. MAIT cell activation and dynamics associated with COVID-19 disease severity. Sci. Immunol. 5, eabe1670 (2020).

PubMed  PubMed Central  Google Scholar 

Legoux, F., Salou, M. & Lantz, O. MAIT cell development and functions: the microbial connection. Immunity 53, 710–723 (2020).

CAS  PubMed  Google Scholar 

Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477–481 (2012).

CAS  PubMed  PubMed Central  Google Scholar 

Viana, S. D., Nunes, S. & Reis, F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities–role of gut microbiota dysbiosis. Ageing Res. Rev. 62, 101123 (2020).

CAS  PubMed  PubMed Central  Google Scholar 

Gaibani, P. et al. The gut microbiota of critically ill patients with COVID-19. Front. Cell. Infect. Microbiol. 11, 670424 (2021).

CAS  PubMed  PubMed Central  Google Scholar 

Gu, S. et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin. Infect. Dis. 71, 2669–2678 (2020).

CAS  PubMed  Google Scholar 

Ren, Z. et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut 70, 1253–1265 (2021).

CAS  PubMed  Google Scholar 

Xu, R. et al. Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun. Biol. 4, 240 (2021).

CAS  PubMed  PubMed Central  Google Scholar 

Mizutani, T. et al. Correlation analysis between gut microbiota alterations and the cytokine response in patients with coronavirus disease during hospitalization. Microbiol. Spectr. 10, e0168921 (2022).

PubMed  Google Scholar 

Rafiqul Islam, S. et al. Dysbiosis of oral and gut microbiomes in SARS-CoV-2 infected patients in Bangladesh: elucidating the role of opportunistic gut microbes. Front. Med. 9, 163 (2022).

Google Scholar 

Reinold, J. et al. A pro-inflammatory gut microbiome characterizes SARS-CoV-2 infected patients and a reduction in the connectivity of an anti-inflammatory bacterial network associates with severe COVID-19. Front. Cell. Infect. Microbiol. 11, 1154 (2021).

Google Scholar 

Tang, L. et al. Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity. Engineering 6, 1178–1184 (2020).

CAS  PubMed  Google Scholar 

Tao, W. et al. Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18. Med. Microecol. 5, 100023 (2020).

PubMed  PubMed Central  Google Scholar 

Wu, Y. et al. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes 7, 61 (2021).

CAS  PubMed  PubMed Central  Google Scholar 

Yeoh, Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698–706 (2021).

CAS  PubMed  Google Scholar 

Li, S. et al. Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota. Front. Microbiol. 12, 712081 (2021).

PubMed  PubMed Central  Google Scholar 

Zuo, T. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159, 944–955.e8 (2020).

CAS  PubMed  Google Scholar 

Bolte, E. E., Moorshead, D. & Aagaard, K. M. Maternal and early life exposures and their potential to influence development of the microbiome. Genome Med. 14, 4 (2022).

PubMed  PubMed Central  Google Scholar 

de Steenhuijsen Piters, W. A., Binkowska, J. & Bogaert, D. Early life microbiota and respiratory tract infections. Cell Host Microbe 28, 223–232 (2020).

PubMed  Google Scholar 

Renz, H. & Skevaki, C. Early life microbial exposures and allergy risks: opportunities for prevention. Nat. Rev. Immunol. 21, 177–191 (2021).

CAS  PubMed  Google Scholar 

Zhang, X.-S. et al. Maternal cecal microbiota transfer rescues early-life antibiotic-induced enhancement of type 1 diabetes in mice. Cell Host Microbe 29, 1249–1265.e9 (2021).

CAS  PubMed  PubMed Central  Google Scholar 

Sarkar, A., Yoo, J. Y., Valeria Ozorio Dutra, S., Morgan, K. H. & Groer, M. The association between early-life gut microbiota and long-term health and diseases. J. Clin. Med. 10, 459 (2021).

PubMed  PubMed Central  Google Scholar 

Xu, R. et al. Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19. J. Genet. Genomics 48, 803–814 (2021).

CAS